OakChart

SelectQuote Inc

SLQTFinancial·Insurance Brokers·USA·Micro·NYSE·Nov 11 • 12:43 PM ET

0.5250+0.0678 (14.83%)
2026-11-11 18:45 CET
Market cap
82.04 USD m
Revenue, TTM
1,569.69 USD m
Net income, TTM
-4.17 USD m
Free cash flow, TTM
32.52 USD m
EPS diluted, TTM
-0.02
P/E
-
Compare

Price

SLQT against its 20, 50 and 200-day averages
2050200earnings
0.501.001.509.0M18.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SLQTclose 0.5320-day 0.3850-day 0.42200-day 0.730.5352w low

70.2% under the 52-week high of 1.76 on 12 Jan 2026. 52-week low 0.30 on 20 Oct 2026. Last 15 sessions, 99.3% high to low

Profile

SLQT
52-week range, 15% of the way up
0.301.76

SelectQuote, Inc. is a technology-enabled, direct-to-consumer distribution and engagement platform, which engages in the sale of insurance policies and provision of healthcare services. It operates through the following segments: Senior, Healthcare Services, and Life. The Senior segment primarily sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other senior health insurance products. The Healthcare Services segment provides pharmacy, chronic care management, and other healthcare products and services through SelectRx, Healthcare Select, and SelectPatient Management. The Life segment primarily sells term life and final expense products. The company was founded on August 18, 1999 and is headquartered in Overland Park, KS.

Employees4039
IPOMay 21, 2020
Beta1.91
ATR, 14d0.06
Rel volume2.80
Short float1.45%
Insider own20.07%
Inst own36.54%

Snapshot

6 groups

Valuation

Index-
Market Cap94.21M
Enterprise Value810.02M
Income-4.17M
Sales1.57B
Book/sh1.74
Cash/sh0.07
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees4039
IPOMay 21, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S0.06
P/B0.30
P/C7.01
P/FCF2.90
EV/EBITDA7.40
EV/Sales0.52
Quick Ratio2.00
Current Ratio2.00
Debt/Eq0.65
LT Debt/Eq0.61
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.02
EPS next Y-0.28
EPS next Q0.13
EPS this Y-550.00%
EPS next Y27.47%
EPS next 5Y-
EPS past 3/5Y44.00% -
Sales past 3/5Y17.30% 11.72%
EPS Y/Y TTM-111.57%
Sales Y/Y TTM0.42%
EPS Q/Q18.10%
Sales Q/Q-14.84%
EarningsNov 04 BMO
EPS/Sales Surpr.36.34% 0.75%

Ownership

Insider Own20.07%
Insider Trans2.61%
Inst Own36.54%
Inst Trans-3.68%
ROA5.88%
ROE12.28%
ROIC7.12%
Gross Margin36.35%
Oper. Margin5.85%
Profit Margin-0.27%
SMA2037.63%
SMA5025.49%
SMA200-28.47%
Trades-

Technical

Shs Outstand179.42M
Shs Float143.44M
Short Float1.45%
Short Ratio1.53
Short Interest2.08M
52W High1.76 -70.17%
52W Low0.30 75.06%
Volatility22.63% 11.83%
ATR (14)0.06
RSI (14)63.23
Beta1.91
Rel Volume2.80
Avg Volume1.36M
Volume2,004,003

Performance

Perf Week6.84%
Perf Month51.52%
Perf Quarter-26.47%
Perf Half Y-53.13%
Perf YTD-62.77%
Perf Year-67.19%
Perf 3Y-58.33%
Perf 5Y-95.27%
Perf 10Y-
Recom2.00
Target Price2.10
Prev Close0.46
Price0.52
Change %14.83%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 21, 2025InitiatedJJefferiesHold$2.75+423.8%
Sep 30, 2024InitiatedCCraig HallumBuy$4.50+757.1%
Feb 29, 2024InitiatedNNoble Capital MarketsOutperform$5+852.4%
Apr 01, 2022ResumedCCredit SuisseNeutral$4+661.9%
Feb 08, 2022ReiteratedRRBC Capital MktsSector Perform$13 → $3+471.4%
Feb 08, 2022ReiteratedBBarclaysEqual Weight$9 → $5+852.4%
Feb 08, 2022DowngradePPiper SandlerOverweight → Neutral$20 → $4+661.9%
Feb 08, 2022DowngradeCCredit SuisseOutperform → Neutral$14 → $4+661.9%
Feb 08, 2022DowngradeCCitigroupBuy → Neutral$14 → $4+661.9%
Jan 18, 2022DowngradeBBarclaysOverweight → Equal Weight$21 → $9+1,614.3%

Peers

Mkt cap
TickerCompanyMkt cap
EHTHeHealth Inc14.63M
TREELendingTree Inc513.03M
LIFEEthos Technologies Inc2.52B
TWFGTWFG Inc1.45B
GSHDGoosehead Insurance Inc1.58B
EVEREverQuote Inc1.00B
MAXMediaAlpha Inc850.59M
QNSTQuinStreet Inc1.08B
HUMHumana Inc53.42B
ALHCAlignment Healthcare Inc1.62B

Insider trading

latest 14 of 21
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Weldon Raymond FDirectorNov 06 '26Buy0.49409,836200,820923,050Nov 10 04:42 PM
Grant William Thomas IIICHIEF OPERATING OFFICERNov 06 '26Buy0.5179,60040,1983,468,094Nov 10 04:42 PM
Hawks Donald L IIIDirectorNov 09 '26Buy0.46223,402102,542763,214Nov 10 04:41 PM
Hawks Donald L IIIDirectorNov 06 '26Buy0.4426,59811,677539,812Nov 10 04:41 PM
Danker Timothy RobertCHIEF EXECUTIVE OFFICERNov 06 '26Buy0.50100,66850,7373,076,073Nov 10 04:41 PM
Grant Robert ClayPRESIDENTNov 06 '26Buy0.5179,80140,3003,386,491Nov 10 04:41 PM
Clement Ryan MooreChief Financial OfficerAug 01 '26Option Exercise0.00275,1960597,589Aug 04 09:16 PM
Anderson Sarah Taylor(See Remarks)Aug 01 '26Option Exercise0.0085,3220136,947Aug 04 09:16 PM
Fisher Stephanie D.Chief Accounting OfficerAug 01 '26Option Exercise0.0057,1830161,765Aug 04 09:16 PM
Danker Timothy RobertCHIEF EXECUTIVE OFFICERAug 01 '26Option Exercise0.00630,39403,254,988Aug 04 09:16 PM
Matthews Joshua BrandonPresident, SelectQuote SeniorAug 01 '26Option Exercise0.00150,9320776,876Aug 04 09:16 PM
Grant Robert ClayPRESIDENTAug 01 '26Option Exercise0.00610,79403,502,128Aug 04 09:16 PM
Grant William Thomas IIICHIEF OPERATING OFFICERAug 01 '26Option Exercise0.00525,32803,563,136Aug 04 09:15 PM
Boulware Daniel AllenGENERAL COUNSEL AND SECRETARYAug 01 '26Option Exercise0.00217,0140506,686Aug 04 09:15 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
VFHVanguard Financials ETFAUM: 13.58B
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B

News

latest 14 of 206
  • SelectQuote Beats On Margin Repair, But Shrinking Revenue And A Reverse-Split Vote Keep The Pressure On (Earnings Whispers) +19.85%
  • SelectQuote: Fiscal Q1 Earnings Snapshot (Associated Press)
  • SelectQuote, Inc. Reports First Quarter of Fiscal Year 2027 Results (Business Wire)
  • SelectQuote's Shrink-To-Profit Pivot Faces First Test As Stock Sinks Toward 30 Cents (Earnings Whispers) +8.04%
  • SelectQuote to Release Fiscal First Quarter 2027 Earnings on November 4 (Business Wire)
  • Loading…
  • SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook (InvestorsHub) -29.34%
  • SelectQuote: Fiscal Q4 Earnings Snapshot (Associated Press)
  • SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results (Business Wire)
  • SelectQuote to Release Fiscal Fourth Quarter and Full Year 2026 Earnings on August 25 (Business Wire)
  • SelectQuote Announces Participation in Upcoming RBC Global Healthcare Conference on May 20 (Business Wire) +6.25%
  • SelectQuote: Fiscal Q3 Earnings Snapshot (Associated Press) +52.43%
  • SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results (Business Wire)
  • SelectQuote to Release Fiscal Third Quarter 2026 Earnings on May 5 (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-11-04-0.210-0.330-280.01277.914
2026Q42026-08-25-0.190-0.165-0.191321.65353.444
2026Q32026-05-050.110-0.0080.113430.93438.934
2026Q22026-02-050.2600.2180.268537.1530.734
2026Q12025-11-06-0.260-0.280-0.258328.81316.744
2025Q42025-08-21-0.020-0.185-0.110345.1334.094
2025Q32025-05-120.1100.0230.035408.16412.833
2025Q22025-02-100.3000.0970.304481.14473
2025Q12024-11-04-0.260-0.197-0.261292.26275.83
2024Q42024-09-13-0.180-0.155-0.183307.21272.952
2024Q32024-05-090.0500.0300.050376.4339.72
2024Q22024-02-070.1100.1100.114405.44376.41
2024Q12023-11-02-0.190-0.270-0.185232.73203.51
2023Q42023-09-13-0.290-0.289-0.287221.78181.413
2023Q32023-05-100.060-0.1260.055299.4260.693
2023Q22023-02-070.1400.0300.135319.19300.213

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.8320.460-0.099531.52509.77
2021FY0.7900.8390.754937.82936.97
2022FY-1.810-1.317-1.814764.05829.36
2023FY-0.350-0.353-0.3521,003965.36
2024FY-0.200-0.175-0.2031,3221,288
2025FY0.140-0.0430.0131,5271,515
2026FY-0.060-0.028-1,6181,650
2027FY--0.390--1,387
2028FY--0.283--1,451

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-11-08411442.65434.39449
2027Q2S2026-11-05412442.65434.39449
2027Q2S2026-11-04412442.65434.39449
2027Q2S2026-10-26402444.94436.41457.49
2027Q2S2026-08-25402444.94436.41457.49
2027Q2S2026-07-19200526.46492.39560.53
2027Q2S2026-05-05202526.46492.39560.53
2027Q2S2026-04-22200547.64520.53574.75
2027Q2S2026-04-21210547.64520.53574.75
2027Q2S2026-02-06211547.64520.53574.75
2027Q2S2026-02-05201544.26520.53567.99
2027Q2S2026-01-21200558.87549.75567.99
2027Q2S2025-11-11201558.87549.75567.99
2027Q2S2025-11-10201558.87549.75567.99

Estimate history

EPS, annual0.2150.448-0.0990.754-1.814-0.352-0.2030.013-0.062-0.0219
Period201820192020202120222023202420252026TTM
EPS, quarterly-0.2610.3040.035-0.11-0.2580.2680.113-0.191-0.211
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual233.688337.469531.515929.981764.0451002.8481321.7761526.5941618.4991569.69
Period201820192020202120222023202420252026TTM
Sales, quarterly292.263481.069408.16345.102328.811537.102430.933321.653280.007
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual10.18510.887162.191163.51164.452166.867169.385172.817176.47179.421
Period201820192020202120222023202420252026MRQ
Shares, quarterly171.497172.126172.721172.817175.947176.276176.348176.47179.421
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1,569.691,618.501,526.591,321.781,002.85764.04929.98531.51337.47
Cost of Goods Sold Incl. D&A999.141,044.00939.47723.80527.49466.81270.71167.40104.42
Gross Profit570.56574.50587.13597.97475.36297.24659.27364.12233.05
Selling, General and Administrative Excl. Other478.70498.46499.80520.27463.78609.76467.03231.79134.46
Research and Development38.2838.9738.6833.5226.0224.7318.6212.358.33
Other Operating Expense0.000.000.000.000.00455.700.000.000.00
Operating Income91.8676.0487.3377.7111.58-301.41192.24132.3398.59
Interest Expense43.6944.5374.4079.1671.1743.5930.0425.761.66
Unusual Expense-38.90-45.03-40.7013.160.0044.603.310.002.31
Net Income Before Taxes87.4376.2948.51-29.07-69.14-389.81158.01106.1694.61
Income Taxes15.0914.100.935.06-10.60-92.3033.1625.0222.03
Consolidated Net Income72.3562.1947.58-34.12-58.54-297.50124.8681.1572.58
Net Income From Continuing Operations72.3562.1947.58-34.12-58.54-297.50124.8681.1572.58
Net Income-4.17-11.6525.03-34.12-58.54-297.50124.86-16.0072.58
EPS (Recurring)-0.16-0.23-0.14-0.15-0.35-1.620.77-0.100.46
EPS (Basic, Before Extraordinaries)-0.02-0.060.14-0.20-0.35-1.810.77-0.100.45
EPS (Diluted)-0.02-0.060.01-0.20-0.35-1.810.75-0.100.45
EBITDA109.5193.53107.78102.7139.46-276.69208.44140.32103.19
Non-Operating Income (Expense)0.35-0.26-5.11-14.46-9.55-0.20-0.87-0.41-0.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense10.4811.7414.5010.918.835.573.446.930.06
Price To Earnings Ratio------24.3450.6355.61
Price To Sales Ratio0.050.100.280.350.320.533.437.73-
Gross Margin36.3535.5038.4645.2447.4038.9070.8968.5169.06
Operating Margin5.854.705.725.881.16-39.4520.6724.9029.22
Net Margin-0.27-0.721.64-2.58-5.84-38.9413.43-3.0121.51
Shares Outstanding179.42176.47172.82169.38166.87164.45163.51162.1910.89
Market Capitalization82.0482.04411.08466.88324.98407.723,146.894,098.824,105.30

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue280.01321.65430.93537.10328.81345.10408.16481.07
Cost of Goods Sold Incl. D&A217.32218.44254.86308.53262.18242.06242.72257.34
Gross Profit62.69103.22176.08228.5766.63103.05165.44223.73
Selling, General and Administrative Excl. Other87.4399.15139.51152.60107.19110.10137.57146.07
Research and Development9.239.689.789.609.9141.599.9710.04
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-24.744.0636.5675.97-40.56-7.0527.8777.66
Interest Expense10.9710.5010.6011.6111.8110.9320.4123.72
Unusual Expense-8.726.65-18.20-18.63-14.85-28.71-27.1714.36
Net Income Before Taxes-26.52-13.1344.1282.95-37.669.3834.6039.56
Income Taxes-6.223.713.9313.66-7.20-3.498.58-13.68
Consolidated Net Income-20.30-16.8440.2069.29-30.4612.8726.0253.24
Net Income From Continuing Operations-20.30-16.8440.2069.29-30.4612.8726.0253.24
Net Income-40.46-36.3021.4251.17-47.94-3.8920.2353.24
EPS (Recurring)-0.24-0.170.050.20-0.31-0.22-0.070.36
EPS (Basic, Before Extraordinaries)-0.21-0.190.110.27-0.26-0.020.110.31
EPS (Diluted)-0.21-0.190.110.27-0.26-0.110.030.30
EBITDA-20.288.5440.9580.30-36.26-2.1832.8082.72
Non-Operating Income (Expense)0.46-0.04-0.03-0.04-0.14-1.36-0.04-0.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.162.672.912.753.423.833.923.71
Price To Earnings Ratio-68.94------
Price To Sales Ratio0.050.100.070.170.230.290.420.45
Gross Margin22.3932.0940.8642.5620.2629.8640.5346.51
Operating Margin-8.831.268.4814.14-12.34-2.046.8316.14
Net Margin-14.45-11.284.979.53-14.58-1.134.9611.07
Shares Outstanding179.42176.47176.35176.28175.95172.82172.72172.13
Market Capitalization82.04148.33110.97248.12338.72411.08574.96638.00

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments20.7235.7342.6983.16141.00286.45368.870.570.96
Short Term Receivables305.55283.46270.89267.44248.08194.47136.8895.9479.02
Inventories0.000.008.765.575.750.180.000.000.00
Other Current Assets24.6821.8410.587.0613.702.338.096.453.59
Total Current Assets350.95341.04332.92363.22402.77483.42513.83102.9683.57
Net Property, Plant & Equipment32.5639.2142.4151.0269.8260.9222.1513.7611.08
Total Investments and Advances0.961.330.0017.860.000.000.000.000.00
Long-Term Note Receivable852.67818.75761.45729.35722.35756.78461.75279.49196.09
Intangible Assets48.3546.4753.6154.0876.69121.3074.6510.266.29
Deferred Tax Assets234.16235.98238.81232.45223.97124.1854.25--
Other Assets1.342.553.523.73886.271.441.410.480.52
Total Assets1,520.981,485.331,432.721,451.701,514.031,548.041,128.04406.94297.56
Short Term Debt Incl. Current Port. of LT Debt27.0873.7450.6939.1912.577.840.053.950.03
Accounts Payable74.0359.2036.5927.5824.7734.0822.8913.3510.59
Other Current Liabilities91.5179.9687.3170.5076.1866.9072.8715.9213.66
Total Current Liabilities192.62212.91174.59137.26113.51108.8295.8133.2224.28
Long Term Debt370.94343.77663.23692.62732.50497.46311.8722.3520.42
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities283.61273.85276.29272.03274.05263.00160.0981.2559.61
Other Liabilities23.7979.281.812.832.8611.7214.587.495.94
Total Liabilities870.96909.821,115.911,104.731,122.92881.00582.36144.31110.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value298.21224.370.000.000.000.000.000.170.17
Common Equity351.81351.14316.80346.97391.11667.04545.69262.45187.13
Total Shareholders Equity650.02575.52316.80346.97391.11667.04545.69262.63187.30
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity650.02575.52316.80346.97391.11667.04545.69262.63187.30
Total Liabilities & Stockholders Equity1,520.981,485.331,432.721,451.701,514.031,548.041,128.04406.94297.56
Book Value Per Share1.992.031.872.082.384.083.3624.1118.37
Tangible Book Value Per Share1.721.761.551.761.913.342.9023.1617.76
Full-Time Employees4,0394,2694,2924,1864,3673,3001,900--
Price to Book Ratio0.261.171.350.941.044.677.5336.92-
Return on Assets4.143.26-2.37-3.95-19.659.3310.5720.60-
Return on Equity10.1510.66-10.28-15.86-76.0720.5920.0832.26-
Return on Invested Capital6.095.18-3.48-5.63-26.4810.729.4625.4716.80
Quick Ratio1.821.601.862.613.504.445.363.103.44
Current Ratio1.821.601.912.653.554.445.363.103.44

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income72.3562.1947.58-34.12-58.54-297.50124.8681.1572.58
Depreciation17.6517.4920.4625.0027.8824.7216.147.994.70
Other Funds (Non Cash)-22.10-22.87-11.7241.1844.8765.7817.0812.740.43
Funds from Operations79.2768.3958.1733.223.03-299.71191.08126.8899.70
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-42.87-36.51-72.31-19.51-32.52-33.46-306.53-188.66-99.59
Cash from Operating Activities36.4031.89-14.1413.71-29.49-333.17-115.44-61.780.11
Capital Expenditures-15.81-16.15-11.31-11.67-9.12-34.65-22.99-15.55-8.64
Net Assets From Acquisitions0.000.000.00-3.430.00-6.93-41.03-35.820.00
Sale of Fixed Assets and Businesses0.000.000.000.250.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00-1.000.000.000.00
Purchase of Investments0.000.000.000.000.00-1.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-15.81-16.15-11.31-14.85-9.12-42.58-64.02-51.37-8.64
Cash Dividends Paid0.000.000.000.000.000.000.00-275.00-1.96
Change in Capital Stock0.000.00330.880.081.193.18-3.79140.514.27
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00-0.03
Sale of Common Pref Stock0.000.00330.880.081.193.18-3.79140.514.30
Proceedsfrom Stock Options0.000.00330.780.000.000.00-5.680.000.00
Issuance or Reduction of Debt, Net-20.77-28.58-306.01-39.03-17.99232.76143.50282.745.86
Change in Long Term Debt-20.77-28.58-306.01-39.03-17.990.00143.50282.745.86
Issuance of Long Term Debt754.50665.50266.000.000.000.00227.87513.21151.56
Reduction of Long Term Debt-775.27-694.09-572.00-39.03-17.990.00-84.37-230.47-145.71
Net Financing Active Other Cash Flow-1.20-2.54-5.03-0.37-2.42-5.65-42.66333.200.00
Other Financing Activities Uses-1.20-2.54-5.03-0.37-2.42-5.65-42.66-7.000.00
Cash from Financing Activities-21.97-31.1319.84-39.33-19.23230.2997.04481.458.13
Net Change in Cash-1.38-15.39-5.62-40.47-57.84-145.46-82.42368.30-0.39
Free Cash Flow32.5227.61-16.3410.32-30.93-357.97-130.35-71.22-3.81
Preferred Dividends (Cash Flow)---0.000.000.000.00-0.00
Price to Free Cash Flow2.385.73-45.06-----
Deferred Taxes & Investment Tax Credit-11.581.851.16-11.18-92.7233.0125.0121.99

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments13.4420.7235.2122.2014.4635.73
Short Term Receivables330.37305.55311.13380.69297.88283.46
Inventories0.000.000.000.000.000.00
Other Current Assets22.1824.6820.9021.9319.6221.84
Total Current Assets365.99350.95367.24424.81331.96341.04
Net Property, Plant & Equipment30.3232.5634.8137.2737.9939.21
Total Investments and Advances0.880.961.041.141.241.33
Intangible Assets48.3748.3547.5147.0546.9146.47
Deferred Tax Assets-234.16---235.98
Other Assets1.151.341.411.252.442.55
Total Assets1,251.981,520.981,334.711,352.261,206.981,485.33
Short Term Debt Incl. Current Port. of LT Debt25.8427.0827.1224.9973.2273.74
Accounts Payable59.1974.03103.2080.4334.5759.20
Other Current Liabilities98.3091.51100.77129.35107.9479.96
Total Current Liabilities183.32192.62231.10234.78215.73212.91
Long Term Debt385.04370.94376.00409.27349.62343.77
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities40.08283.6145.2142.0928.70273.85
Other Liabilities12.2023.7918.9046.4865.9979.28
Total Liabilities620.65870.96671.22732.62660.05909.82
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value318.37298.21278.76259.98241.86224.37
Common Equity312.96351.81384.73359.66305.07351.14
Total Shareholders Equity631.34650.02663.49619.64546.93575.52
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity631.34650.02663.49619.64546.93575.52
Total Liabilities & Stockholders Equity1,251.981,520.981,334.711,352.261,206.981,485.33
Book Value Per Share1.741.992.182.041.732.03
Tangible Book Value Per Share1.471.721.911.771.471.76
Full-Time Employees-4,039---4,269
Price to Book Ratio0.260.390.310.810.961.17
Return on Assets5.884.146.995.915.243.26
Return on Equity12.2810.1515.0516.4415.1110.66
Return on Invested Capital-2.00-1.653.876.73-3.401.40
Quick Ratio2.001.821.591.811.541.60
Current Ratio2.001.821.591.811.541.60

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income-20.30-16.8440.2069.29-30.4612.87
Depreciation4.464.484.384.324.304.88
Other Funds (Non Cash)-7.8119.13-20.88-12.55-8.58-21.89
Funds from Operations-33.0211.0126.8374.46-43.90-6.72
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital15.84-6.6022.29-74.4022.21-30.76
Cash from Operating Activities-17.184.4149.120.05-21.70-37.48
Capital Expenditures-3.65-4.56-3.95-3.65-3.98-3.11
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-3.65-4.56-3.95-3.65-3.98-3.11
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.00-0.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.00-0.01
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net14.59-14.42-32.2211.296.77-8.54
Change in Long Term Debt14.59-14.42-32.2211.296.77-8.54
Issuance of Long Term Debt169.0080.27328.23177.0080.000.00
Reduction of Long Term Debt-154.41-94.69-360.45-165.72-73.23-8.54
Net Financing Active Other Cash Flow-1.12-0.01-0.03-0.05-2.46-0.01
Other Financing Activities Uses-1.12-0.01-0.03-0.05-2.46-0.01
Cash from Financing Activities13.47-14.43-32.2511.234.31-8.56
Net Change in Cash-7.36-14.5812.927.64-21.37-49.16
Free Cash Flow-17.843.2348.17-1.04-22.75-37.98
Price to Free Cash Flow2.385.78-32.04--

Revenue breakdown

Pharmacy2025: 728.75M
Service2025: 797.84M
Total Insurance Agents, Brokers & Service revenue2026: 1.62B
United States2025: 1.53B 2026: 1.62B
Auto & Home2025: 18.03M
Consolidation, Policy2025: -7.51M
Healthcare Services2025: 742.71M
Life2025: 172.98M
Senior2025: 600.39M
Total Insurance Agents, Brokers & Service revenue2026: 1.62B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.45%2.1M143.4M1.19M
2026-10-151.04%1.5M143.3M1.08M
2026-09-301.30%1.9M142.8M1.07M
2026-09-151.16%1.7M142.6M1.43M
2026-08-311.60%2.2M140.4M1.52M
2026-08-141.13%1.6M140.3M1.46M
2026-07-311.12%1.6M140.3M2.10M
2026-07-151.13%1.6M141.9M2.13M
2026-06-300.94%1.3M141.9M2.07M
2026-06-153.10%4.4M141.9M1.74M
2026-05-293.23%4.4M137.3M1.81M
2026-05-153.37%4.6M137.3M1.73M
2026-04-303.66%5.0M137.3M1.40M
2026-04-153.77%5.2M137.2M1.41M
2026-03-313.47%4.8M137.2M1.50M
2026-03-132.25%3.1M137.2M1.46M
2026-02-272.43%3.3M137.2M1.29M
2026-02-132.42%3.3M137.2M1.26M
2026-01-301.81%2.5M137.3M1.11M
2026-01-151.71%2.3M137.1M1.09M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.100.052.19621534.000.674-0.0040.000
call1.000.000.050.004.3990.000.000.293-0.0070.000
call1.500.000.850.005.8850.000.000.253-0.0090.000
call2.000.000.050.007.1410.000.000.251-0.0090.000
call3.000.000.850.007.8900.000.000.217-0.0110.000
call4.000.000.750.008.6360.000.000.208-0.0110.000
put0.500.000.100.240.00085.000.00-0.363-0.0050.000
put1.000.100.600.557.05615.000.00-0.707-0.0070.000
put1.500.501.101.208.53812.000.00-0.747-0.0090.000
put2.001.001.601.629.48316.000.00-0.765-0.0090.000
put3.002.002.602.7010.7112.000.00-0.783-0.0100.000
put4.003.003.603.5011.5305.001.00-0.792-0.0110.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-09-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-10SEC
2026-09-18PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-10SEC
2026-08-2510-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-258-KCurrent report2026-08-25SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-07-08SCHEDULE 13G/ASEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-19144Filing for proposed sale of securities under Rule 144.SEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-03-258-KCurrent report2026-03-19SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-02-28SEC
2026-03-034Statement of changes in beneficial ownership of securities2025-11-11SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-02-28SEC
2026-02-194Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-13SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11446.27K600
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05004.08K1
2026-040000
2026-030000
2026-02105.02K100
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
ABRAMS BISON INVESTMENTS, LLC4.49%
Mariner, LLC3.72%
VANGUARD CAPITAL MANAGEMENT LLC3.46%
AQR CAPITAL MANAGEMENT LLC1.40%
CAPTRUST FINANCIAL ADVISORS1.34%
BlackRock, Inc.1.24%
Qube Research & Technologies Ltd1.22%
JANE STREET GROUP, LLC1.21%
Diametric Capital, LP1.12%
GEODE CAPITAL MANAGEMENT, LLC0.94%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.42%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
Fidelity Small Cap Index Fund0.79%
Fidelity Enhanced Small Cap Core ETF0.42%
VANGUARD RUSSELL 2000 INDEX FUND0.41%
Schwab U.S. Small-Cap ETF0.38%
BlackRock Advantage Small Cap Core Fund0.31%
Fidelity Extended Market Index Fund0.29%
Schwab Small-Cap Index Fund0.17%
EA Bridgeway Omni Small-Cap Value ETF0.17%

OakChart. SLQT. Cached 15 minutes.